Pathway Diagnostics

Pathway Diagnostics "is an innovator in the development of novel biomarker assays. Integrating biomarker testing services for pharma clinical trials with a growing portfolio of proprietary assay technology, we aim to bring to market the next generation of diagnostic tools. Our corporate headquarters and laboratory comprise 20,000 square feet of a landmark technology office park campus in Malibu, California."

People
Accessed December 2007:

Senior Officers

 * Wally Narajowski, President & Chief Executive Officer
 * Bart E. Thielen, Chief Financial Officer
 * Joseph Lanfreschi, Ph.D., VP of Laboratory & Clinical Trials Operations
 * Terry Robins, Ph.D., VP of Research & Development
 * Stephanie H. Astrow, Ph.D., MBA, VP, Director of Oncology
 * Allen R. Gehrke, National Sales Director, Clinical Trials

Directors

 * Lionel Carnot, Director
 * Richard Daly, Director
 * E. Rolland Dickson, M.S., M.D., Director
 * William G. Gerber, M.D., Chairman
 * David V. Milligan, Ph.D., Director
 * Wally Narajowski, President & Chief Executive Officer
 * Nicholas J. Pritzker, Director

Contact

 * Web: http://www.pathwaydx.com